BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260610T080000
DTEND;TZID=Europe/Brussels:20260611T200000
DTSTAMP:20260525T135146
CREATED:20260216T122037Z
LAST-MODIFIED:20260422T072615Z
UID:9464-1781078400-1781208000@www.europabio.org
SUMMARY:Bio Innovations Europe 2026
DESCRIPTION:EuropaBio is joining Bio Innovations Europe 2026 as a Headline Partner. \n\n\n\nTaking place on 10-11 June 2026 in The Hague\, the event—formerly known as World Bio Markets—has seen exponential growth. Since its 2022 relaunch\, pre-arranged meetings have surged from 160 to over 1\,050 in 2025—a 550% increase. The 2026 edition is set to be the largest yet\, hosting more than 400 attendees and facilitating 1\,500 commercial meetings between bio-developers & producers\, chemical manufacturers\, consumer brands & intermediates\, community enablers\, investors & financiers and suppliers. \n\n\n\nDelivering the Biotech future of Europe: EuropaBio at Bio-Innovations \n\n\n\nEuropaBio\, the industry association that champions innovative bioindustries\, is proud to host a dedicated programme together with partner Bio-Innovations. \n\n\n\nEFIB presents Europe’s key opinion leaders\, bringing a clear statement to legislators at EU and national levels. 2026 brings legislation for simplification\, defragmentation and acceleration of biotechnology as a vital global technology and Europe must ensure that it can compete in the global race to dominance for biotechnology and biomanufacturing. \n\n\n\nIn addition to an opening keynote\, where the 2026 EFIB Statement will be launched\, EuropaBio\, through its EFIB platform\, will also host dedicated workshops: \n\n\n\nExecutive Round Table: Senior stakeholders from across the corporate\, policy and scientific community will discuss the priorities for Europe in 2026 and the ambition that must be delivered through legislative programmes that include the Bioeconomy Strategy\, Biotech Act and Food and Feed Safety Omnibus\, in addition to industrial policy levers including the European Competitiveness Fund\, EU Inc. and STEP regulation. \n\n\n\nSME Breakfast: The engine of innovation\, the SME breakfast will bring together the entrepreneurs that translate Europe’s research excellence into products\, delivering economic growth and supply chain resilience. The meeting will discuss their challenges and needs\, resulting in the 2026 SME Statement for Industrial Biotechnology\, published following the conference. \n\n\n\n25% discount for EuropaBio’s network: BIEUEB \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/bio-innovations-europe-2026/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-37.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260611T090000
DTEND;TZID=Europe/Brussels:20260611T133000
DTSTAMP:20260525T135146
CREATED:20260424T102431Z
LAST-MODIFIED:20260424T102433Z
UID:9607-1781168400-1781184600@www.europabio.org
SUMMARY:European Biotech Forum 2026
DESCRIPTION:EuropaBio is a proud sponsor of the European Biotech Forum 2026. \n\n\n\nBiotechnology is becoming a decisive capability for Europe’s competitiveness\, industrial resilience and strategic autonomy. But Europe enters the next institutional cycle with a fragmented policy landscape\, uneven regulatory capacity\, and persistent scale-up barriers. The Commission’s Biotech Communication I and Biotech Communication II set out an initial toolbox\, but fall short of an end-to-end industrial framework comparable to the US. The gap between ambition and execution remains significant. To what extent do these communications address the core challenges of Europe’s biotech sector? Where are the structural gaps that still block growth and industrial deployment? \n\n\n\n\nMore Info & Registration Here
URL:https://www.europabio.org/event/european-biotech-forum-2026/
CATEGORIES:EuropaBio,External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/04/Event-Banners-Website-1-1.png
END:VEVENT
END:VCALENDAR